KESTRA MEDICAL TECHNOLOGIES, LTD. 1Q 2027: Revenue $30.97M, EPS $(0.75) — 10-Q Summary
KESTRA MEDICAL TECHNOLOGIES, LTD. reported first-quarter 2027 results for the three months ended July 31, 2026, with revenue of $30.97M, up 60% year over year, and a net loss attributable to common shareholders of $(44.09)M. Diluted EPS was $(0.75), compared with $(0.50) in the year-ago quarter.Fin…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.